{"id":"https://openalex.org/W2550255152","doi":"https://doi.org/10.1182/blood.v104.11.5030.5030","title":"Safety, Tolerability, and Pharmacokinetic Assessment of CG53135 Administered Intravenously in Patients with Advanced (Stage 4) Cancer (Single Rising-Dose Tolerance).","display_name":"Safety, Tolerability, and Pharmacokinetic Assessment of CG53135 Administered Intravenously in Patients with Advanced (Stage 4) Cancer (Single Rising-Dose Tolerance).","publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W2550255152","doi":"https://doi.org/10.1182/blood.v104.11.5030.5030","mag":"2550255152"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v104.11.5030.5030","doi":"https://doi.org/10.1182/blood.v104.11.5030.5030","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.5030.5030","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103699184","display_name":"Joe Stephenson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Joe Stephenson","raw_affiliation_strings":["Clinical Research, Cancer Center of the Carolinas, Greenville, SC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Cancer Center of the Carolinas, Greenville, SC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029455802","display_name":"Sanjay Goel","orcid":"https://orcid.org/0000-0002-2798-7568","observed_orcids":["https://orcid.org/0000-0002-2798-7568"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sanjay Goel","raw_affiliation_strings":["Oncology, Albert Einstein Comprehensive Cancer Center Weiler Hospital, Bronx, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Albert Einstein Comprehensive Cancer Center Weiler Hospital, Bronx, NY, USA","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042529049","display_name":"Pankaj Bhargava","orcid":"https://orcid.org/0000-0002-0647-1386","observed_orcids":["https://orcid.org/0000-0002-0647-1386"]},"institutions":[{"id":"https://openalex.org/I4210162397","display_name":"UMass Memorial Medical Center","ror":"https://ror.org/053v00853","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1303243448","https://openalex.org/I166722992","https://openalex.org/I4210162397"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Pankaj Bhargava","raw_affiliation_strings":["Hematology/Oncology, U. of Massachusetts Memorial Medical Center, Worcester, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, U. of Massachusetts Memorial Medical Center, Worcester, MA, USA","institution_ids":["https://openalex.org/I4210162397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009177808","display_name":"Saroj Vadhan\u2010Raj","orcid":"https://orcid.org/0000-0002-6790-8457","observed_orcids":["https://orcid.org/0000-0002-6790-8457"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saroj Vadhan-Raj","raw_affiliation_strings":["Bioimmunotherapy, MD Anderson, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioimmunotherapy, MD Anderson, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053715398","display_name":"V. Annino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Vincent Annino","raw_affiliation_strings":["Clinical Development, CuraGen Corporation, Branford, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, CuraGen Corporation, Branford, CT, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109156759","display_name":"Thomas R. Hawthorne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Thomas Hawthorne","raw_affiliation_strings":["Clinical Development, CuraGen Corporation, Branford, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, CuraGen Corporation, Branford, CT, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007529506","display_name":"Yuan\u2010Di C. Halvorsen","orcid":"https://orcid.org/0000-0003-2490-8024","observed_orcids":["https://orcid.org/0000-0003-2490-8024"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yuan-Di Halvorsen","raw_affiliation_strings":["Clinical Development, CuraGen Corporation, Branford, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, CuraGen Corporation, Branford, CT, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110162975","display_name":"William F. Hahne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"William Hahne","raw_affiliation_strings":["Clinical Development, CuraGen Corporation, Branford, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, CuraGen Corporation, Branford, CT, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5007529506","https://openalex.org/A5029455802","https://openalex.org/A5042529049","https://openalex.org/A5053715398","https://openalex.org/A5103699184","https://openalex.org/A5109156759","https://openalex.org/A5110162975"],"corresponding_institution_ids":["https://openalex.org/I129975664","https://openalex.org/I4210162397"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.43804252,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"104","issue":"11","first_page":"5030","last_page":"5030"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12198","display_name":"Oral health in cancer treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12198","display_name":"Oral health in cancer treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11452","display_name":"Oral Health Pathology and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3506","display_name":"Periodontics"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-mucositis","display_name":"oral mucositis","score":0.871999979019165},{"id":"https://openalex.org/keywords/chemotherapy-induced-mucositis","display_name":"chemotherapy-induced mucositis","score":0.8349999785423279},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.9570000171661377},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7559999823570251},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8309999704360962},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8420000076293945},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.6899999976158142},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7129999995231628},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.3109999895095825},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.6880000233650208},{"id":"https://openalex.org/keywords/neuropathy","display_name":"neuropathy","score":0.38199999928474426},{"id":"https://openalex.org/keywords/premature-atrial-contractions","display_name":"premature atrial contractions","score":0.6010000109672546},{"id":"https://openalex.org/keywords/neuropathic-pain","display_name":"neuropathic pain","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9220328330993652},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.9152891635894775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7543251514434814},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6962687969207764},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6904388666152954},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43824371695518494},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4360677897930145},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43040895462036133},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4246482253074646},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4003220796585083},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37368208169937134},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.36944591999053955}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v104.11.5030.5030","doi":"https://doi.org/10.1182/blood.v104.11.5030.5030","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.5030.5030","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2591270258","https://openalex.org/W2107815060","https://openalex.org/W2000164775","https://openalex.org/W2034578924","https://openalex.org/W2575442903","https://openalex.org/W1508285630","https://openalex.org/W2570038188","https://openalex.org/W2050775091","https://openalex.org/W2044738098","https://openalex.org/W2596270525"],"abstract_inverted_index":{"Abstract":[0],"Oral":[1],"mucositis":[2,56,326],"(OM)":[3],"is":[4,15,374,390],"a":[5,27,54,138,180],"common":[6],"complication":[7],"in":[8,45,53,75,122,126,357],"cancer":[9,301],"patients":[10,79],"receiving":[11,342,363],"chemotherapy":[12],"(CT).":[13],"OM":[14,49,147,318],"characterized":[16],"by":[17,90,104],"damage":[18],"to":[19,66,97,115,136,154,220,231,270,292,369],"the":[20,23,68,91,105,132,156,191,217,232,281,310,347],"epithelium":[21],"of":[22,60,73,77,160,190,340,355,365,395],"oral-pharyngeal":[24],"cavity.":[25],"CG53135-05,":[26],"recombinant":[28],"human":[29],"fibroblastic":[30],"growth":[31],"factor":[32],"20":[33],"(rhFGF-20)":[34],"protein,":[35],"has":[36],"demonstrated":[37],"epithelial":[38],"and":[39,47,71,85,101,131,148,158,251,260,305,383],"mesenchymal":[40],"cell":[41],"proliferation":[42],"stimulating":[43],"activity":[44],"vitro":[46],"reduces":[48],"using":[50],"single":[51,181,378],"doses":[52],"hamster":[55],"model.":[57],"The":[58,142,162,202,392],"goal":[59],"this":[61,358,396],"dose-escalating":[62],"tolerance":[63],"study":[64,233,282,293,397],"was":[65,112,134,207,284,319],"assess":[67],"safety,":[69],"tolerability":[70,116],"pharmacokinetics":[72],"CG53135-05":[74,170,195,373],"cohorts":[76],"four":[78],"(pts)":[80],"at":[81,118,171,381,387],"0.03,":[82],"0.1,":[83,98],"0.33,":[84],"1mg/kg":[86],"(concentrations":[87],"are":[88,95,165],"determined":[89],"UV":[92],"method":[93,107],"which":[94],"equivalent":[96],"0.3,":[99],"1.0,":[100],"3.0":[102],"mg/kg":[103,120,140,173,177,389],"Bradford":[106],"previously":[108],"used).":[109],"Dose":[110],"escalation":[111],"stopped":[113],"due":[114,219],"information":[117],"0.33":[119],"delivered":[121],"15":[123],"min":[124,209],"(reported":[125],"another":[127],"Phase":[128],"I":[129],"study)":[130],"protocol":[133],"amended":[135],"add":[137],"0.2":[139,388],"dose.":[141],"World":[143],"Health":[144],"Organization":[145],"(WHO)":[146],"OMAS":[149],"scoring":[150],"systems":[151],"were":[152,268,295],"used":[153],"measure":[155],"incidence":[157],"severity":[159],"OM.":[161],"interim":[163],"results":[164,394],"reported:":[166],"Ten":[167],"pts":[168,215,299,322,333,341,349,361],"received":[169,351],"0.03":[172,382],"(n=4)":[174],"or":[175,275,316],"0.1":[176,384],"(n=6)":[178],"as":[179,353],"100-ml":[182],"intravenous":[183],"infusion":[184],"administered":[185],"3":[186,274,315],"days":[187],"after":[188],"completion":[189],"CT.":[192],"After":[193],"infusion,":[194],"reached":[196],"maximum":[197],"plasma":[198],"concentration":[199],"within":[200],"1h.":[201],"mean":[203],"terminal":[204],"exponential":[205],"half-life":[206],"49":[208],"(range:":[210],"16.2\u201387":[211],"min,":[212],"n=5).":[213],"No":[214,272,332],"discontinued":[216],"trial":[218],"adverse":[221,288],"experiences.":[222],"Adverse":[223],"events":[224,289],"(number":[225],"pts)":[226],"that":[227,327],"may":[228],"be":[229,399],"related":[230],"drug":[234,283,294],"include:":[235],"nausea":[236],"(2);":[237,239,241],"chills":[238],"fever":[240],"vomiting":[242],"(1);":[243,245,253,255,257,259],"dizziness":[244],"vision":[246],"-":[247],"\u201clights":[248],"flashing\u201d":[249],"(1)":[250],"astigmatism":[252],"neuropathy":[254],"tachycardia":[256],"headache":[258],"premature":[261],"atrial":[262],"complex":[263],"(1).":[264],"All":[265],"reported":[266],"incidences":[267],"mild":[269,368],"moderate.":[271],"grade":[273,314],"4":[276,317],"laboratory":[277],"toxicity":[278],"associated":[279],"with":[280,377],"noted.":[285],"Three":[286,321],"serious":[287],"deemed":[290],"unrelated":[291],"noted":[296],"from":[297],"two":[298,360],"including":[300],"progression,":[302],"catheter":[303],"infection,":[304],"small":[306],"intestinal":[307],"obstruction.":[308],"Among":[309],"treated":[311],"pts,":[312],"no":[313],"observed.":[320],"developed":[323],"Grade":[324],"2":[325],"lasted":[328],"between":[329],"1\u20135":[330],"days.":[331],"required":[334],"total":[335],"parenteral":[336],"nutrition.":[337],"Approximately":[338],"72\u201384%":[339],"CPT-11":[343,352],"experience":[344],"diarrhea.":[345,371],"Of":[346],"six":[348],"who":[350],"part":[354],"CT":[356],"trial,":[359],"(both":[362],"0.03mg/kg":[364],"CG53135-05)":[366],"experienced":[367],"moderate":[370],"Conclusions:":[372],"well":[375],"tolerated":[376],"dose":[379],"administration":[380],"mg/kg.":[385],"Dosing":[386],"ongoing.":[391],"full":[393],"will":[398],"presented.":[400]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2016-11-30T00:00:00"}